AEBi — raw details

Highlights

1 patentProfile claimed by owner

About

Therapeutic Peptides for Personalized Cancer Treatment

Accelerated Evolution Biotechnologies (AEBi) is a development-stage biopharmaceutical company engaged in the discovery and development of therapeutic peptides. The company has developed an IP-protected combinatorial biology screening platform technology that can be used to find binders to known targets and select the best functional molecules among them. AEBis platform is extremely flexible, harnessing combinatorial biology to discover new and better lead compounds to disease targets. AEBi was incorporated at the Weizmann Institutes ITEK technological incubator in Nes-Tziona, Israel. The company has a collaboration agreement with Israeli biopharmaceutical company Proteologics.

Identity

Name	AEBi
Slug	accelerated-evolution-biotechnologies-aebi
Type / kind	startup
Crunchbase ID	aebi-accelerated-evolution-biotechnologies
Source _id	agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ7po-0LDA

Status

Status	active
Last update	2026-05-17

Location

HQ country code	IL
HQ region/district	Center District
HQ city	Ness Ziona
HQ address	Einstein St 13, Ness Ziona, Israel

Web & social

Website	https://aebi-bio.com
LinkedIn	https://www.linkedin.com/company/18348278

Classifications

Primary sector Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

BiologicalsMolecules

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business models

B2B

Funding

Total raised	—
Current stage	Pre-Funding

Raw source document

Show full JSON (0 KB)

{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}